CelLBxHealth plc is a CTC intelligence company specializing in circulating tumour cell (CTC) solutions for research, drug development, and clinical oncology. Its Parsortix® platform harvests CTCs from blood and integrates with existing laboratory instruments for downstream analysis, including whole-cell imaging and genomic workflows. The company generates revenue through product sales of the Parsortix platform and consumables, laboratory services for clinical trials, and lab-developed tests pursued via partnerships and in-house development.